More articles from Imaging and Therapy with Large Antibodies and Proteins

You have access
Engineered DOTA antibody with infinite affinity for in vivo tracking of lymphocytes
Simone Krebs, Hanwen Zhang, Afruja Ahad, Juan Zurita, Larissa Shenker, Steven Larson, Vladimir Ponomarev, Stephen Gottschalk, Prasad Adusumilli and Wolfgang Weber

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 46;
You have access
Development of an α-fetoprotein derived peptide-based theranostic agent for specific targeting of estrogen receptor positive breast cancers
Subhani Okarvi and Ibrahim Aljammaz

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 51;
You have access
Comparative efficacy and toxicity of ¹⁷⁷Lu- vs ⁹⁰Y-theranostic anti-HER2/anti-DOTA(metal) pretargeted radioimmunotherapy (anti-HER2 DOTA-PRIT) of HER2-expressing breast cancer xenografts with curative intent.
Sarah Cheal, Edward Fung, Hong Xu, Hong-fen Guo, Miteshkumar Patel, Meghan Bell, Teja Kalidindi, Blesida Punzalan, Pat Zanzonico, K Wittrup, Steven Larson and Nai-Kong Cheung

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 54;
You have access
Novel Dual Receptor enhanced Pretargeting strategy for PET imaging
Lingyi Sun, Yongkang Gai, Xiaohui Zhang and Dexing Zeng

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 48;
You have access
Feasibility of 124I anti-PD-L1 PET / CT imaging in a syngeneic tumor model of breast cancer.
Bennett Chin, Thomas Hawk, Douglas Weitzel, Darryl McDougald, Robert Reiman, Gregory Palmer, Michael Zalutsky and Ganesan Vaidyanathan

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 47;
You have access
Next-Generation Radioimmunotherapy: Characterizing Humanized and Fully Human Monoclonal Anti-CD20 Antibodies Labeled with Zirconium-89
Jason Yoon, Mark Longtine, Bernadette Marquez-Nostra and Richard Wahl

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 49;
You have access
Fluorescence labeled human serum albumin as an imaging agent for a SPARC(secreted protein acidic and rich in cysteine) expressing glioblastoma
JUNGHWAN JO, Myung Geun Song, Ji Yong Park, Hyewon Youn, June-Key Chung, Jae Min Jeong, Yun-Sang Lee and Keon Wook Kang

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 53;
You have access
A general method for site-specific labeling of antibodies with ⁸⁹Zr: improved immuno-reactivity and tumor retention of ⁸⁹Zr-trastuzumab in a HER2 positive xenograft mouse model
Lotte Kristensen, Camilla Christensen, Camilla Knudsen, Mette Jensen, Brian Agnew, Andreas Kjaer and Carsten Nielsen

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 52;
You have access
The UniCAR system: Biodistribution and kinetics of the ⁶⁴Cu-labeled anti EGFR target module in mice
Ralf Bergmann, Susann Albert, Anja Feldmann, Nicole Berndt and Michael Bachmann

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 50;

Main menu

User menu

Search

More articles from Imaging and Therapy with Large Antibodies and Proteins